Plasma Amprenavir Pharmacokinetics and Tolerability following Administration of 1,400 Milligrams of Fosamprenavir Once Daily in Combination with either 100 or 200 Milligrams of Ritonavir in Healthy Volunteers

Once-daily (QD) fosamprenavir (FPV) at 1,400 mg boosted with low-dose ritonavir (RTV) at 200 mg is effective when it is used in combination regimens for the initial treatment of human immunodeficiency virus infection. Whether a lower RTV boosting dose (i.e., 100 mg QD) could ensure sufficient ampren...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ruane, Peter J., Luber, Andrew D., Wire, Mary Beth, Lou, Yu, Shelton, Mark J., Lancaster, C. Tracey, Pappa, Keith A.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2007
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1797779/
https://ncbi.nlm.nih.gov/pubmed/17088488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00560-06
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires